StocksDeepDive
Snapshot · Russell 3000 · generated 2026-11-11 21:49 UTC

IRMD — IRADIMED CORPORATION

EXPENSIVE (MOS -95.9%) · Quality 79/100

Value Score 30 days ago: 17.7 → today 19.1

Price
86.58
Intrinsic value
44.2
Margin of safety
-95.9%
Implied growth (reverse DCF)
+30.8%
model assumes +17.7%
Value Score
19.1
Quality
79
Psychology
0.7
Discovery
8.5
price/volume attention only
Moat score
85
erosion: none

Value Score: bottom 28% of Russell 3000 · Quality: top 5%

Dividend: 1.27/share (TTM) · yield 1.5% · payout 67%

Open the interactive Deep Dive for IRMD →

Use this data programmatically

This page's numbers are also available as JSON at /api/v1/deep-dive/IRMD - see the API docs for the full read-only surface, including an MCP server for AI assistants.

Common questions

Is IRMD undervalued?

As of 2026-11-11, IRMD trades at 86.58 against a computed intrinsic value of 44.2 (-95.9% margin of safety) - StocksDeepDive's valuation label for this is EXPENSIVE. This is a described calculation from public data, not a recommendation.

What is IRADIMED CORPORATION's Value Score?

IRADIMED CORPORATION's Value Score is 19.1 as of 2026-11-11 - it combines value, quality, crowd psychology and market attention into one number.

Does IRMD pay a dividend?

Yes - IRMD's trailing twelve-month dividend is 1.27/share, a yield of 1.5% at the current price (as of 2026-11-11).